NGNicole M.F. Van Gerven

Nicole M.F. Van Gerven

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nicole M.F. Van Gerven has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Annemiek A. Van der Eijk

    Department of Virology, Erasmus Medical Centre, Rotterdam, The Netherlands

    1 shared publication
  • Birgit I. Witte

    Department of Epidemiology and Biostatistics, VU University Medical Centre,Amsterdam, The Netherlands

    1 shared publication
  • Carin M.J. Van Nieuwkerk

    Department of Gastroenterology and Hepatology, VU University Medical Centre, Amsterdam, The Netherlands

    1 shared publication
  • Chris J.J. Mulder

    Department of Gastroenterology and Hepatology, VU University Medical Centre, Amsterdam, The Netherlands

    1 shared publication
  • Gerd Bouma

    Department of Gastroenterology and Hepatology, VU University Medical Centre, Amsterdam, The Netherlands

    1 shared publication
  • Hans L. Zaaijer

    Department of Blood-Borne Infections, Sanquin Blood Supply Foundation, Amsterdam, The Netherlands

    1 shared publication

Latest Publications

  • Open Access

    Seroprevalence of Hepatitis E Virus in Autoimmune Hepatitis Patients in the Netherlands

    by Nicole M.F. Van Gerven, Annemiek A. Van der Eijk, Suzan D. Pas, Hans L. Zaaijer, Ynto S. De Boer, Birgit I. Witte, Carin M.J. Van Nieuwkerk, Chris J.J. Mulder, Gerd Bouma, Robert A. De Man

    Background & Aims: In recent years chronic courses of hepatitis E virus (HEV) infection have been described in immunosuppressed individuals. This may implicate a potential role for HEV in the development of autoimmune diseases, including autoimmune hepatitis (AIH). Here we investigated the prevalence of HEV-antibodies in AIH patients in an endemic Central European country. Methods: HEV-specific immunoglobulin G (IgG) and HEV RNA were determined in 354 and 377 AIH patients, respectively. Clinical characteristics and disease outcome parameters were retrospectively collected. Results: No HEV viraemic patients were identified in this cohort. A total of 106 AIH patients (29.9%) tested positive for anti-HEV IgG, and this figure was slightly higher compared to the prevalence in a reference cohort including 5,329 healthy Dutch blood donors (26.7%; P>0.05). Conclusion: This is the largest study on the association between HEV infection and AIH. Apparently silent HEV infection is present in a significant proportion of AIH patients, yet appears not to have significant clinical repercussions in this immune compromised group of patients. Nevertheless, since acute hepatitis E may present with histological and biochemical features of AIH, the possibility of a (concomitant) HEV infection should be considered in this category of patients.Abbreviations: AIH: autoimmune hepatitis; ALT: alanine aminotransferase; SMA: anti smooth muscle antibodies; ANA: antinuclear antibodies; PBC: primary biliary cirrhosis; AMA: anti mitochondrial antibodies; PSC: primary sclerosing cholangitis.